Gene variant could predict PTSD; Skyline, Clavis look into leukemia biomarkers;

> Variants of a gene that plays a role in regulating serotonin might serve as a predictor for post-traumatic stress disorder, according to data published in the Archives of General Psychiatry. Release

> Dutch biotech Skyline Diagnostics is getting together with Norway's Clavis Pharma to investigate gene expression biomarkers for acute myeloid leukemia. Item

> Adding two biomarkers to a scoring system, called GRACE, that predicts risk for acute coronary syndromes, did not improve the system's accuracy. Release

> FDA gives Fujirebio Diagnostics 510(k) clearance to market the company's test to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery. More here

> Molecular diagnostics company Vermillion has been awarded a new patent, number 8,014,952 , "Serum Biomarkers in Lung Cancer." Release

> Biomarkers can help predict which treatment ulcerative colitis patients will respond to. Item

Suggested Articles

The CE Mark for the system’s fourth iteration follows a July 2019 approval from the FDA.

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.